At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
HD-tDCS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in Logopenic Variant Primary Progressive Aphasia (lvPPA): Effects on Language and Neural Mechanisms
In Brief
A clinical study evaluating HD-tDCS and Sham for Primary Progressive Aphasia. Completed, enrolled 6 participants across 1 site.
Detailed Summary
This study aims to evaluate the effectiveness of a therapy called High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for the treatment of the language deficits experienced by people with a type of Primary Progressive Aphasia. This study uses a combination of brain imaging, language assessment, language training sessions, and HD-tDCS therapy as well as placebo therapy sessions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Progressive Aphasia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 2019
Enrollment StartFeb 2020
Primary CompletionMay 2022
TodayJul 2026
First PostedJan 16, 2019
Enrollment StartFeb 24, 2020
Primary CompletionMay 18, 2022
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.5 years ago
Interventions
HD-tDCSdevice
High-Dose transcranial Direct Current Stimulation
Shamdevice
Sham sessions (no electric current)